2017 annual financial data
Dyne Therapeutics 2017 Operating cash flow margin
Direct answer
Operating cash flow margin was 115.61%.
Operating income was -412,000,000 USD and net income was 76,000,000 USD.
Operating cash flow was 585,000,000 USD.
Get free Dyne Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 506,000,000 USD
- Operating income
- -412,000,000 USD
- Net income
- 76,000,000 USD
- Operating cash flow
- 585,000,000 USD